[1] Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial[J]. J Am CollCardiol, 2007, 49(12):1272-1278.
[2] 张鑫,邱建平,沈卫峰. PCI围术期应用大剂量他汀研究进展[J]. 国际心血管病杂志, 2011, 38(6):331-333.
[3] Chang X, Feng J, Ruan L, et al. Positive correlation between neovascularization degree of carotid atherosclerosis determined by contrast-enhanced ultrasound and level of serum C-reactive protein[J]. Vasa, 2015, 44(3):187-194.
[4] Puato M, Zambon A, Faggin E, et al. Statin treatment and carotid plaque composition: a review of clinical studies[J]. Curr Vasc Pharmacol, 2014, 12(3):518-526.
[5] Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE(Atorvastatin for Reduction of Myocardial Damage During Angioplasty)randomized trial[J]. J Am Coll Cardiol, 2009, 54(6):558-565.
[6] Luo KQ, Long HB, Xu BC. Reduced apoptosis after acute myocardial infarction by simvastatin[J]. Cell Biochem Biophys, 2015, 71(2):735-740.